CarolineHastingsMD

Pediatric Hematology & Oncology • Oakland, CA

Physician

Join to view full profile

Dr. Hastings is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hastings' full profile

Already have an account?

Office
747 52nd Street
Oakland, CA 94609
Phone+1 510-428-3631

Fax+1 510-601-3916

Education & Training

Children's Hospital-OaklandFellowship, Pediatric Hematology/Oncology, 1989 - 1992
Children's Hospital-OaklandResidency, Pediatrics, 1986 - 1989
University of California, Davis, School of MedicineClass of 1986

Certifications & Licensure

CA State Medical License 1987 - 2026
NV State Medical License 1992 - 2019
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes Start of enrollment: 2004 Nov 01
Completed
Not Applicable
PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children Start of enrollment: 2012 Dec 13
Active, not recruiting
Phase 2
Vemurafenib in Children With Recurrent/Refractory BRAF Gene V600E (BRAFV600E)-Mutant Gliomas Start of enrollment: 2014 Apr 29
Active, not recruiting
Early Phase 1
Open-Label Study of Long-Term Safety and Efficacy of Intravenous Trappsol Cyclo (HPβCD) in Niemann-Pick Disease Type C Start of enrollment: 2019 May 23
Active, not recruiting
Phase 1
Join now to see all

Publications & Presentations

PubMed

29 citations
Expanded access with intravenous hydroxypropyl-β-cyclodextrin to treat children and young adults with Niemann-Pick disease type C1: a case report analysis.
Caroline Hastings, Camilo Vieira, Benny Liu, Cyrus Bascon, Claire Gao
Orphanet Journal of Rare Diseases. 2019-10-21
25 citations
Outcomes after late bone marrow and very early central nervous system relapse of childhood B-acute lymphoblastic leukemia: a report from the Children's Oncology Group ...
Glen Lew, Yichen Chen, Xiaomin Lu, Susan R. Rheingold, James A. Whitlock
Haematologica. 2020-01-30
18 citations
Intravenous 2-hydroxypropyl-β-cyclodextrin (Trappsol® Cyclo™) demonstrates biological activity and impacts cholesterol metabolism in the central nervous system and per...
Caroline Hastings, Benny Liu, Bryan Hurst, Gerald F Cox, Sharon Hrynkow
Molecular Genetics and Metabolism. 2022-12-01

Press Mentions

Cyclo Therapeutics Announces Publication of Phase 1 Data for Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C1 (NPC1)October 18th, 2022
Cyclo Therapeutics Provides Business UpdateSeptember 29th, 2022
Cyclo Therapeutics Appoints Caroline Hastings, M.D. As Global Principal Investigator for Ongoing TransportNPC™ Study Evaluating Trappsol® Cyclo™ for the Treatment of Niemann-Pick DiseaseDecember 9th, 2021
Join now to see all